The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCropper (J) Regulatory News (CRPR)

Share Price Information for Cropper (J) (CRPR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 345.00
Bid: 330.00
Ask: 360.00
Change: 0.00 (0.00%)
Spread: 30.00 (9.091%)
Open: 345.00
High: 345.00
Low: 345.00
Prev. Close: 345.00
CRPR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

10 Nov 2020 07:00

RNS Number : 7378E
Cropper(James) PLC
10 November 2020
 

 

The advanced materials and paper products group, is pleased to announce its

Half year results to 26 September 2020

 

 

Half year to 26 September 2020

Half year to 28 September 2019

Full year to 28 March 2020

 

£m

£m

£m

Revenue

34.0

52.8

104.7

Adjusted operating (loss) / profit *

(1.2)

2.8

7.2

Operating profit

0.4

2.6

6.6

Adjusted (loss) / profit before tax *

(1.4)

2.6

6.7

Impact of IAS 19

(0.3)

(0.6)

(1.2)

Impact of exceptional items

1.7

-

-

Profit before tax

0.0

2.0

5.5

Earnings per share - basic and diluted

(0.2p)

17.0p

50.6p

Dividend per share declared

nil

2.5p

2.5p

 

 

 

 

Net borrowings

(5.2)

(15.3)

(11.1)

Equity shareholders' funds

27.3

21.9

34.4

Gearing % - before IAS 19 deficit

12%

38%

26%

Gearing % - after IAS 19 deficit

19%

70%

32%

Capital expenditure

1.4

3.3

9.2

* excludes the impact of IAS 19 and exceptional items (per note 9)

Highlights

· The key priority remains the safety and wellbeing of employees

· Rapid response to Covid 19 to reduce costs, optimise cash flow and protect liquidity

· Group revenues down 36% on prior year mainly within the Paper division

· Colourform revenues up 17% on prior year

· The downturn in TFP sales, particularly in the aerospace sector mitigated by growth in medical and renewable energy sectors

· Restructuring costs nearing completion with a net cost of £0.2m projected for the year and £2m savings pa thereafter.

· Company has liquidity of over £14m including cash and available overdraft facilities.

· Capital investments for future growth to restart in the second half

· To protect liquidity, no interim dividend declared.

 

Mark Cropper, Chairman, commented:

"Our immediate key priority is to maintain the safety and wellbeing of our employees and customers. Each division is seeing signs of recovery with most markets trending back to normality. The restructuring plans are nearing completion with a small net cost anticipated for the year but anticipated savings of £2m p.a. in future years. The restructuring has affected less than 10% of the workforce but will result in a leaner, stronger Group. Capital investment was suspended during the first half of the year and is planned to resume in the second half."

"The Group has weathered a major challenge during the period. The actions of our employees to meet and overcome the challenge has been exceptional across the Group. I am proud of their actions and commitment as ever and would like to thank them all for their continued efforts to protect themselves, their fellow employees and the business as we plan to come out of this pandemic a stronger, fitter Group and continue our plans for growth."

Enquiries:

Isabelle Maddock, Chief Financial Officer

Robert Finlay, Henry Willcocks, John More

James Cropper PLC (AIM:CRPR.L)

Shore Capital

Telephone: +44 (0) 1539 722002

Telephone: +44 (0) 20 7408 4090

www.jamescropper.com

 

 

 

 

Half year to 26 September 2020

Half year to 28 September 2019

Full year to 28 March 2020

Summary of results

£'000

£'000

£'000

Revenue

34,004

52,792

104,667

 

 

 

 

Adjusted operating loss / (profit)*

(1,196)

2,826

7,240

 

 

 

 

Operating profit

352

2,554

6,569

 

 

 

 

Adjusted (loss) / profit before tax *

(1,445)

2,557

6,674

 

 

 

 

Impact of IAS19

(293)

(548)

(1,215)

 

 

 

 

Exceptional items (note 8)

1,722

-

-

 

 

 

 

Loss / profit before tax

(16)

2,009

5,459

* excludes the impact of IAS 19 and exceptional items (per note 9)

 

Half year to 26 September 2020

Half year to 28 September 2019

Full year to 28 March 2020

 

£'000

£'000

£'000

Revenue

 

 

 

Paper division

20,856

37,992

75,545

Colourform division

1,414

1,211

2,586

Technical Fibre Products division

11,734

 

13,589

26,536

 

34,004

52,792

104,667

 

 

 

 

Adjusted operating (loss) / profit *

(1,196)

2,826

7,240

Adjusted net interest

(249)

(269)

(566)

Adjusted (loss) / profit before tax *

(1,445)

2,557

6,674

 

 

 

 

IAS19 pension adjustments

 

 

 

Net current service charge against operating profits

(174)

(273)

(671)

Finance costs charged against interest

(119)

(275)

(544)

 

(293)

(548)

(1,215)

Exceptional items (note 8)

1,722

-

-

Loss / profit before tax

(16)

2,009

5,459

* excludes the impact of IAS 19 and exceptional items (per note 9)

Balance sheet summary

Half year to 26 September 2020

Half year to 28 September 2019

Full year to 28 March 2020

 

£'000

£'000

£'000

Non-pension assets - excluding cash

69,854

71,320

72,084

Non-pension liabilities - excluding borrowings

(22,517)

(15,704)

(19,032)

 

47,337

55,616

53,052

 

 

 

 

Net IAS19 pension deficit (after deferred tax)

(14,791)

(18,351)

(7,600)

 

32,546

37,265

45,452

Net borrowings

(5,220)

(15,323)

(11,055)

 

Equity shareholders' funds

27,326

21,942

34,397

Gearing % - before IAS19 deficit

12%

38%

26%

Gearing % - after IAS19 deficit

19%

70%

32%

Capital expenditure

1,367

3,284

9,195

 

 

 

 

 

Dear Shareholders

 

The last six months have been a challenging period for the Group, particularly for our employees, customers, suppliers, local communities and shareholders. The impact of the pandemic has been significant, but due to the actions taken at the onset, the Group remains in a strong position.

 

The Group responded quickly to the challenges. Throughout the crisis we have managed our response under three headings: the health and wellbeing of our employees, supporting customers and reducing costs. The overall objective has been to emerge from the pandemic a stronger Group. The commitment, support and engagement of our employees in such an adverse time has been truly remarkable: everyone has excelled in protecting the business and each other. Immediate actions included working from home where possible whilst continuing to support our customer needs and cutting non-essential expenditure to reduce costs. Employee safety was a primary focus with enhanced safety measures introduced to provide a Covid-19 secure environment in line with government and NHS guidelines.

 

The Group took swift action to reduce costs and protect liquidity. This included the deferral of all discretionary spending, suspension of major capital expenditure, suspension of dividend payments, and seeking support from local authorities, government agencies and the banks. During the period, our customers, particularly in the Paper division were globally impacted by Covid-19, leading to reduced demand and periods of inefficient or no production. This resulted in many employees being placed on furlough. In addition, payment of the bonuses earned from our record results last year have been deferred until the second half of the year. No bonuses or annual incremental pay increases will be implemented in the current year.

 

The Group has weathered the initial impact of the pandemic. All divisions in the business have been impacted to varying degrees with Paper affected the most, TFP more resilient and Colourform continuing to grow. Markets are improving but it is too early to say whether the Group may be affected by further lockdowns. With this in mind, the Group has prepared projections and continues to protect liquidity. With this backdrop the Board has decided not to declare an interim dividend.

 

As reported in our trading update at the AGM, the Group has been developing restructuring plans for some time in order to drive growth and competitiveness. The impact of the pandemic has required us to accelerate the implementation of these plans, which affect our Paper and Group operations divisions. Most of the restructuring has now been completed and has impacted less than 10% of our employees.

 

Financial Performance

 

Revenue in the period was 36% lower than the prior comparative period at £34.0m (2019: £52.8m). Operating profit in the period was 86% lower than the prior period at £0.4m (2019: £2.6m). Provisions for exceptional costs relating to the restructuring plans are expected to be £1m. The net impact to the Group for the year is expected to be (£0.2m) with savings in future years of £2m p.a.

 

Statutory operating profit for the period was £0.4m after exceptional items for the restructuring costs and grant income from governmental authorities in the UK and USA. This compares to the prior year comparative of £2.6m. The Group had a loss before taxation of £16,000 compared to a profit of £2.0m in the prior year comparative period.

 

The business is in an 18-24 month recovery period. The Company has experienced a trading hit in the first half of 2020-2021 and expects cash generated to be down during the period of the pandemic until we return to more normal trading conditions. We have acted promptly to conserve cash and to implement immediate savings to shore up reserves, in order to continue to protect cash flows and liquidity, the Board has not declared an interim dividend. The Company presently has liquidity of over £14 million including cash and available overdraft facilities thanks to the cash management actions implemented. This is expected to be sufficient to weather further lockdowns, the return to more normal trading conditions and a re-instatement of investment plans to support future growth. Since the period end a £4m CLBIL has been secured which brings additional cash security should it be required as we face continued uncertainty due to Covid-19.

 

James Cropper Paper ("Paper")

The Paper division has been adversely impacted by Covid-19 with revenues down by 45% compared to the comparable period last year, as a result of global lockdowns affecting demand for luxury packaging, education and event collateral. Whilst the division did not have to close completely at any time, a large number of employees were placed on furlough for some time over the period. The Group decided to accelerate restructuring plans during the period, the implementation of which is nearing completion. Whilst there is expected to be a small net cost during the current year, the restructuring will generate significant annual savings. Towards the end of the period positive signs of normality were experienced as markets opened up following the easing of lockdown rules globally.

 

Colourform™ ("Colourform")  

Revenues in the Colourform division grew by 17% in the period; however the rate of growth was impacted by Covid-19. In the period, the division's leadership and growth plans were boosted by the appointment of Patrick Willink as Managing Director. Colourform has reduced production for short periods and placed some employees on furlough during the period.

Technical Fibre Products ("TFP")

Revenues in the TFP division were down by 14% mainly from reduced demand within the aerospace market as a direct result of Covid-19. The drop in the aerospace sector was mitigated by good growth in the medical and green energy sectors, such as hydrogen fuel cells and wind. The division has utilised the furlough scheme for short periods.

 

Pension

The IAS19 valuations, for the two defined benefit schemes as at 26 September 2020, revealed a combined deficit of £18.3m, compared with £9.4m as at 28 March 2020. This change was driven primarily by a large fall in corporate bond yields and a rise in inflation expectations. After deferred taxation the net deficit stands at £14.8m.

 

Earnings per share and dividend

Basic and fully diluted earnings per share decreased to (0.2) pence, compared to 17.0 pence in the prior year comparative period.

 

In order to continue to protect cash flows and liquidity, the Board has not declared an interim dividend.

 

Outlook

Our immediate key priority is to maintain the safety and wellbeing of our employees and customers. Each division is seeing signs of recovery with sectors moving towards normality. The restructuring plans are nearing completion with a small net cost anticipated for the year but anticipated savings of £2m pa in future years. The restructuring has affected less than 10% of the workforce but will result in a leaner, stronger Group. Capital investment was suspended during the first half of the year and is planned to resume in the second half.

The Group has weathered a major challenge during the period. The actions of our employees to meet and overcome the challenge has been exceptional across the Group. I am proud of their actions and commitment as ever and would like to thank them all for their continued efforts to protect themselves, their fellow employees and the business as we plan to come out of this pandemic a stronger, fitter Group and continue our plans for growth.

 

Mark Cropper

Chairman

 

 

 

UN-AUDITED CONSOLIDATED INCOME STATEMENT

 

26 week period

to 26 September 2020

26 week period

to 28 September 2019 

52 week period to 28 March 2020

 

£'000

£'000

£'000

 

 

 

 

Revenue

34,004

52,782

104,667

Provision for impairment

-

-

(308)

Other income

25

32

486

Changes in inventories

(1,383)

205

(1,330)

Raw materials and consumables used

(10,416)

(20,391)

(38,200)

Energy costs

(1,034)

(2,152)

(4,539)

Employee benefit costs

(11,934)

(15,483)

(30,388)

Depreciation and amortisation

(2,158)

(1,911)

(3,950)

Other expenses

(6,752)

(10,538)

(19,869)

Operating profit

352

2,554

6,569

 

 

 

 

Interest payable and similar charges

(370)

(567)

(1,136)

Interest receivable and similar income

2

22

26

(Loss)/profit before taxation

(16)

2,009

5,459

 

 

 

 

Taxation

3

(382)

(630)

(Loss)/profit for the period

(13)

1,627

4,829

 

 

 

 

Earnings per share - basic and diluted

(0.2p)

17.0p

50.6p

 

 

 

 

 

UN-AUDITED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME COMPREHENSIVE INCOME

 

(Loss)/profit for the period

(13)

1,627

4,829

 

Items that are or may be reclassified to profit or loss

 

 

 

Foreign currency translation

(80)

96

181

Cash flow hedges - effective portion of changes in fair value

53

(32)

(295)

 

Items that will never be reclassified to profit or loss

 

 

 

Retirement benefit liabilities - actuarial (loss)/ gain

(8,788)

352

13,057

Deferred tax on actuarial loss / (gain) on retirement benefit liabilities

1,670

(60)

(2,481)

Other comprehensive (expense) / income for the period

(7,145)

356

10,462

Total comprehensive (expense) / income for the period attributable to equity holders of the Company

 

(7,158)

1,983

 

15,291

 

 

 

 UN-AUDITED CONSOLIDATED STATEMENT OF FINANCIAL POSITION

 

 

26 September2020

28 September2019

 28 March 2020

 

£'000

£'000

£'000

Assets

 

 

 

Intangible assets

421

320

495

Property, plant and equipment

32,438

29,521

31,882

Right of use assets

3,468

4,016

4,907

Deferred tax assets

3,471

3,759

1,921

Total non-current assets

39,798

37,616

39,205

 

 

 

 

Inventories

13,550

16,875

13,956

Trade and other receivables

18,656

19,337

19,363

Provision for impairment

(536)

-

(530)

Cash and cash equivalents

11,064

435

8,964

Current tax assets

1,857

1,251

1,872

Total current assets

44,591

37,898

43,625

 

Total assets

 

84,389

 

75,514

 

82,830

Liabilities

 

 

 

Trade and other payables

20,219

14,075

16,544

Other financial liabilities

222

12

275

Loans and borrowings

4,774

1,912

3,756

Total current liabilities

25,215

15,999

20,575

 Long-term borrowings

11,510

13,846

16,263

Retirement benefit liabilities

18,262

22,110

9,382

Deferred tax liabilities

2,076

1,617

2,213

Total non-current liabilities

31,848

37,573

27,858

 

Total liabilities

 

57,063

 

53,572

 

48,433

Equity

 

 

 

Share capital

2,389

2,389

2,389

Share premium

1,588

1,588

1,588

Translation reserve

504

499

584

Reserve for own shares

(1,251)

(1,251)

(1,251)

Retained earnings

24,096

18,717

31,087

Total shareholders' equity

27,326

21,942

34,397

 

Total equity and liabilities

 

84,389

 

75,514

 

82,830

 

 

 

 

 

 

 

UN-AUDITED CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

 

26 week period to 26 September 2020

26 week period

to 28 September 2019

52 week period

to 28 March 2020

 

£'000

£'000

£'000

Cash flows from operating activities

 

 

 

 

Net (loss) / profit

(13)

1,627

4,829

 

 

 

 

Adjustments for:

 

 

 

Tax

(3)

382

630

Depreciation and amortisation

2,158

1,911

3,950

Net IAS 19 pension adjustments within Statement of comprehensive income

293

548

1,215

Past service pension deficit payments

(201)

(734)

(1,424)

Foreign exchange differences

112

(77)

(74)

Loss on disposal of property, plant and equipment

2

-

23

Net bank interest expense

249

269

566

Share based payments

87

188

(252)

Changes in working capital:

 

 

 

 Decrease / (increase) in inventories

386

(454)

2,475

Decrease in trade and other receivables

537

1,644

149

Increase / (decrease) in trade and other payables

3,663

(2,331)

1,719

Tax paid

-

(177)

(741)

Net cash generated from operating activities

7,270

2,796

13,065

Cash flows from investing activities

 

 

 

Purchase of intangible assets

(29)

(34)

(190)

Purchases of property, plant and equipment

(1,338)

(3,250)

(9,005)

Net cash used in investing activities

(1,367)

(3,284)

(9,195)

Cash flows from financing activities

 

 

 

Proceeds from issue of new loans

5,402

913

9,121

Repayment of borrowings

(9,066)

(1,222)

(4,789)

Interest received

2

22

26

Interest paid

(160)

(212)

(434)

Dividends paid to shareholders

-

(1,038)

(1,275)

Net cash (used) / generated in financing activities financingactactivitiesactivities

(3,822)

(1,537)

2,649

Net increase / (decrease) in cash and cash equivalents

2,081

(2,025)

6,519

Effect of exchange rate fluctuations on cash held

19

108

93

Net increase / (decrease) in cash and cash equivalents

2,100

(1,917)

6,612

Cash and cash equivalents at the start of the period

8,964

2,352

2,352

Cash and cash equivalents at the end of the period

11,064

435

8,964

Cash and cash equivalents consists of:

 

 

 

Cash at bank and in hand

11,064

435

8,964

 

 

 

 

 

 

 

 

 

UN-AUDITED CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

 

 

 

Share capital

Share premium

Translation

reserve

Own shares

Retained earnings

 

Total

 

£'000

£'000

£'000

£'000

£'000

£'000

At 28 March 2020

2,389

1,588

584

(1,251)

31,087

34,397

 

 

 

 

 

 

 

Comprehensive (expense) for the period

-

-

-

-

(13)

(13)

 

 

 

 

 

 

 

Total other comprehensive expense

-

-

(80)

-

(7,065)

(7,145)

 

 

 

 

 

 

 

Share based payment charge

-

-

-

-

87

87

Total contributions by and distributions to owners of the Group

-

 

-

 

-

 

-

 

87

 

87

At 26 September 2020

2,389

1,588

504

(1,251)

24,096

27,326

 

 

At 30 March 2019

 

 

2,389

 

 

1,588

 

403

 

 

(1,251)

 

 

18,147

 

 

21,276

Adjustment on initial application of IFRS 16

-

-

-

-

(467)

(467)

At 31 March 2019

2,389

1,588

403

(1,251)

17,680

20,809

 

 

 

 

 

 

 

Comprehensive income for the period

-

-

-

-

1,627

1,627

 

 

 

 

 

 

 

Total other comprehensive income

-

-

96

-

260

356

 

 

 

 

 

 

 

Dividends paid

-

-

-

-

(1,038)

(1,038)

Share based payment charge

-

-

-

-

188

188

Total contributions by and distributions to owners of the Group

 

-

 

-

 

-

 

-

 

(850)

 

(850)

 

At 28 September 2019

 

2,389

 

1,588

 

499

 

(1,251)

 

18,717

 

21,942

 

 

 

 

NOTES TO THE CONDENSED CONSOLIDATED HALF YEAR STATEMENTS

1 BASIS OF PREPARATION

 

James Cropper Plc (the Company) is a public limited company incorporated and domiciled in the United Kingdom and listed on the Alternative Investment Market (AIM). The condensed consolidated half year financial statements of the Company for the twenty six weeks ended 26 September 2020, which have not been audited or reviewed, comprise the Company and its subsidiaries (together referred to as the Group).

Basis of preparation

The condensed consolidated financial statements for the 26 week periods ending 26 September 2020 and 28 September 2019 are unaudited and were approved by the Directors on 9 November 2020. They do not constitute statutory accounts as defined in s434 of the Companies Act 2006. The financial statements for the year ended 28 March 2020 were prepared in accordance with International Financial Reporting Standards (IFRS) and have been delivered to the Registrar of Companies. The report of the auditor on those financial statements was unqualified and did not draw attention to any matters by way of emphasis of matter. The Group's financial statements consolidate the financial statements of James cropper Plc and its subsidiaries.

 

Applicable standards

These unaudited consolidated interim financial statements have been prepared in accordance with International Financial Reporting Standards as adopted by the European Union, under the historical cost convention. They have not been prepared in accordance with IAs 34, the application of which is not required to the interim financial statements of companies trading on the Alternative Investment Market (AIM companies). The interim financial statements have been prepared in accordance with the accounting policies applied in the preparation of the Group's published consolidated financial statements for the 52 week period ended 28 March 2020.

 

The consolidated financial statements of the Group for the 52 week period ended 28 March 2020 are available upon request from the Company's registered office Burneside Mills, Kendal, Cumbria, LA9 6PZ or at www.jamescropper.com.

 

The half year financial information is presented in Sterling and all values are rounded to the nearest thousand pounds (£'000) except where otherwise indicated.

 

Going concern

The Directors, at the time of approving these interim statements, have a reasonable expectation that the Group has adequate resources to continue in operational existence for at least 12 months from this reporting date.

 

In light of the Covid-19 pandemic and subsequent uncertainty, the Group has undertaken a detailed review and taken appropriate mitigating actions to protect the business and liquidity.

 

A robust assessment modelling the most severe impact of the Covid-19 pandemic was carried out in April 2020 and the Company is trading significantly ahead of the most severe forecasts at both sales and profit level. The Group's quick response to Covid-19 has provided financial resilience during this particularly challenging period. Nonetheless the potential of demand decline resulting from Covid-19 establishes an ongoing risk to future financial performance. For the interim going concern review the Group has a base case forecast for the next 30 months to assess the latest position and potential associated ongoing impacts of Covid-19. A number of scenarios assess headroom against facilities and impacts on bank covenants, which showed adequate headroom and no covenant breaches. No revolving credit facilities are due for renewal within the next 12 months. On 27 October 2020, the Company secured a Coronavirus Large Business Interruption Loan ("CLBIL") for a three year duration under which the Group can draw up to £4m. The interim going concern review assumes that this facility remains undrawn.

 

Following this review the Directors are satisfied that the Company and the Group have adequate resources to continue in operational existence for the foreseeable future. Accordingly, they continue to adopt the going concern basis in preparing the condensed consolidated financial statements.

 

Significant accounting policies

The accounting policies applied by the Group in these condensed consolidated financial statements are the same as those applied by the Group in its consolidated financial statements as at and for the 52 week period ended 28 March 2020.

 

 

During the period, some employees across the Group were placed on furlough under the Coronavirus Job Retention Scheme ("JRS"). In addition, in the USA, the subsidiaries of Technical Fibre Products took part in the Paycheck Protection Program ("PPP"). Income from the JRS Scheme and the PPP program of £2.8m has been recognised in the six months ended 26 September 2020. The grants have been recognised as income and matched with associated payroll costs over the same period. These grants have been treated as exceptional in the financial statements for the period ended 28 September 2020. This income has been treated as exceptional in the exceptional items note 8.

 

 

2 Accounting estimates and judgements

The preparation of half year financial statements requires management to make judgements, estimates and assumptions that affect the application of accounting policies and the reported amounts of assets and liabilities, income and expenses. Actual results may differ from these estimates.

The significant judgements made by management in applying the Group's accounting policies and the key sources of estimation uncertainty were the same as those applied to the consolidated financial statements as at and for the 52 week period ended 28 March 2020.

As mentioned in the trading update announcement at the AGM, the Group has accelerated the implementation of a restructuring plan. The plan is still ongoing with costs to date of £495,000. Included in the financial statements for the period ended 26 September 2020 are additional provisions for completion of the plan amounting to a further £562,000. The net impact at the year ended 26 March 2020 is expected to be around £183,000 and generate an annual saving of circa £2m per year. The costs to date and provisions to completion have been recognised in the employee benefits figure of the income statement. The costs have been treated as exceptional and included in the exceptional items note 8.

3 Risks and uncertainties

The principal risks and uncertainties which may have the largest impact on performance in the second half of the year are the same as disclosed in the 2020 Annual Report on pages 21-25. The principal risks set out in the 2020 Annual Report were:

 

Covid-19 pandemic risk; employee health & safety; energy price volatility; pulp price volatility and sustainability; exchange rate volatility; Brexit; pension and information security and cyber risk.

 

The Board considers that the principal risks and uncertainties set out in the 2020 annual report have not changed and remain relevant for the second half of the financial year.

 

4 Alternative performance measures

The Company uses alternative performance measures to allow users of the financial statements to gain a clearer understanding of the underlying performance of the business.

 

Profit before tax represents the Group's overall performance and financial position, however it contains significant non-operational items relating to IAS 19 that the directors believe obscure an understanding of the key performance trend.

 

Measures used to evaluate business performance are 'Adjusted operating profit' (operating profit excluding the impact of IAS 19 and exceptional items), and 'Adjusted profit before tax' (profit before tax excluding the impact of IAS 19 and exceptional items). The alternative performance measures are reconciled in note 9.

 

The adjustment, which we refer to in these accounts as the "IAS 19 impact" represents the difference between the pension charge as calculated under IAS 19 and the cash contributions for the current service cost only as determined by the latest triennial valuation. The Directors consider that the adjusted pension charge better reflects the actual pension costs for ongoing service compared to the IAS 19 charge. This adjustment is made internally when we assess performance and is also used in the EBITDA and EPS targets used in management incentive schemes.

 

5 Earnings per share

 

 

Six months ended 26 September 2020

Six months ended 28 September 2019

Year ended 28 March2020

Earnings per share - basic and diluted

(0.2p)

17.0p

50.6p

(Loss) / Profit for the financial period (£'000)

(16)

1,627

4,829

Weighted average number of shares -

basic and diluted

9,554,803

9,554,803

9,554,803

 

6 Dividends

The group has weathered the initial storm of Covid-19. The Group operates in diverse sectors and in wide geographical markets, so whilst certain parts of the business have been impacted by Covid-19, other parts of the business have demonstrated greater resilience.

With this balance, and the likelihood of a slower recovery, the Board has not declared an interim dividend as it continues to protect the liquidity of the Group.

 

7 Retirement benefit obligations

 

Movements during the period in the Group's defined benefit pension schemes are set out below:

 

26 week period ended 26 September 2020

26 week period ended 28 September 2019

52 week period ended 28 March 2020

 

£'000

£'000

£'000

Obligation brought forward

(9,382)

(22,648)

(22,648)

Expense recognised in the income statement

(528)

(806)

 (1,732)

Contributions paid to the schemes

437

992

1,941

Actuarial (losses) and gains recognised in Other Comprehensive Income

(8,788)

352

13,057

Obligation carried forward

(18,261)

(22,110)

(9,382)

 

 

 

 

8 Exceptional items

 

26 week period ended 26 September 2020

26 week period ended 28 September 2019

52 week period ended 28 March 2020

 

£'000

£'000

£'000

Income from the JRS scheme

2,521

-

-

Income from the PPP program (USA)

258

-

-

Restructuring costs

(1,057)

-

-

Exceptional items

1,722

-

-

 

9 Alternative performance measures

 

 

26 week period ended 26 September 2020

26 week period ended 28 September 2019

52 week period ended 28 March 2020

 

£'000

£'000

£'000

Adjusted operating (loss) / profit

(1,196)

2,826

7,240

Net IAS 19 pension adjustments - current service costs

(174)

(272)

(671)

Grants received JRS scheme

2,521

-

-

PPP program (USA)

258

-

-

Restructuring costs

(1,057)

-

-

Operating profit

352

2,554

6,569

 

 

 

26 week period ended 26 September 2020

26 week period ended 28 September 2019

52 week period ended 28 March 2020

 

£'000

£'000

£'000

Adjusted (loss) / profit before tax

(1,445)

2,557

6,674

Net IAS 19 pension adjustments

 

 

 

- current service costs

(409)

(531)

(1,188)

- future service contributions paid

235

258

517

- finance costs

(119)

(275)

(544)

Grants received - JRS scheme

2,521

-

-

PPP program (USA)

258

-

-

Restructuring costs

(1,057)

-

-

(Loss) / profit before tax

(16)

2,009

5,459

 

10 Related parties

There have been no significant changes in the nature of related party transactions in the period ended 26 September 2020 from that disclosed in the 2020 annual report.

Statement of Directors' responsibilities

The Directors confirm that these condensed consolidated interim financial statements have been prepared in accordance with IAS 34 as adopted by the European Union and that the interim management report includes a fair review of the information required by DTR 4.2.7 and DTR 4.2.8, namely:

(i) An indication of important events that have occurred during the first six months and their impact on the condensed set of financial statements, and a description of the principal risks and uncertainties for the remaining six months of the financial year; and

 

(ii) Material related party transactions in the first six months and any material changes in the related party transactions described in the last Annual report.

 

During the period since approval of the annual report for the 52 weeks ended 28 March 2020, Dave Watson resigned as a director on 1 August 2020.

The Directors of James Cropper Plc are detailed on our Group website www.jamescropper.com

 

Forward-looking statements

Sections of this half-yearly financial report may contain forward-looking statements with respect to the Group's plans and expectations relating to its future performance, results, strategic initiatives, objectives and financial position, including liquidity and capital resources. These forward-looking statements are not guarantees of future performance. By their very nature, all forward-looking statements involve risks and uncertainties because they relate to events that may or may not occur in the future and are or may be beyond the Group's control. Accordingly, the Group's actual results and financial condition may differ materially from those expressed or implied in any forward-looking statements. Forward-looking statements in this half-yearly financial report are current only as of the date on which such statements are made. The Group undertakes no obligation to update any forward-looking statements, save in respect of any requirement under applicable law or regulation. Nothing in this announcement shall be construed as a profit forecast.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR FLFVDLDLAIII
Date   Source Headline
30th Apr 20247:00 amRNSFull Year Trading Update
12th Mar 20243:06 pmRNSDirector/PDMR Shareholding
8th Mar 20242:25 pmRNSDirector/PDMR Shareholding
17th Jan 20247:00 amRNSTrading Update
12th Jan 20247:00 amRNSDirectorate Update
21st Dec 20233:33 pmRNSDirector/PDMR Shareholding
20th Dec 20237:00 amRNSGrant of Awards under Long Term Incentive Plan
27th Nov 20237:00 amRNSBoard Appointment
24th Nov 20232:30 pmRNSDirectorate Change
9th Nov 20237:00 amRNSInterim Results
26th Oct 20237:00 amRNSNotice of Interim Results
26th Sep 20232:50 pmRNSResult of Annual General Meeting
26th Sep 20237:00 amRNSAGM Trading Update
4th Sep 20237:00 amRNSNotice of AGM
31st Aug 20237:00 amRNSInnovative production unit for green hydrogen
29th Aug 202312:43 pmRNSDividend Declaration
24th Aug 20237:00 amRNSFull Year Results
10th Aug 20237:00 amRNSNotice of Full Year Results
14th Jun 20237:00 amRNSDirectorship Change
7th Jun 20237:00 amRNSTFP HYDROGEN ANNOUNCES EXPANSION IN NORTH AMERICA
21st Apr 20235:18 pmRNSDirector/PDMR Shareholding
19th Apr 20237:00 amRNSTrading Update and Overview of Strategy
14th Feb 202312:00 pmRNSDirector/PDMR Shareholding
1st Feb 20237:00 amRNSDirector/PDMR Shareholding
31st Jan 20239:45 amRNSDirector/PDMR Shareholding
2nd Dec 20227:00 amRNSDirector/PDMR Shareholding
18th Nov 20229:48 amRNSDirector/PDMR Shareholding
15th Nov 20227:00 amRNSHalf-year Report
31st Oct 20227:00 amRNSHalf Year Trading Update
23rd Sep 20227:00 amRNSDirector/PDMR Shareholding
23rd Sep 20227:00 amRNSDirector/PDMR Shareholding
12th Sep 202211:03 amRNSDirector/PDMR Shareholding
2nd Sep 20224:40 pmRNSSecond Price Monitoring Extn
2nd Sep 20224:35 pmRNSPrice Monitoring Extension
26th Aug 20227:00 amRNSDirector/PDMR Shareholding
10th Aug 20227:00 amRNSDirectorship Change
5th Aug 202211:45 amRNSDirector/PDMR Shareholding
27th Jul 202211:00 amRNSQ1 Trading Update and AGM Statement
19th Jul 20227:00 amRNSDirector/PDMR Shareholding
8th Jul 202210:34 amRNSDirector/PDMR Shareholding
7th Jul 20227:00 amRNSDirector/PDMR Shareholding
23rd Jun 202210:25 amRNSNotice of AGM and Annual Report & Accounts
21st Jun 20227:00 amRNSFinal Results
12th May 202212:01 pmRNSHolding(s) in Company
24th Mar 20227:00 amRNSDirector/PDMR Shareholding
23rd Mar 20227:00 amRNSTrading Update
26th Jan 20222:30 pmRNSDirector/PDMR Shareholding
21st Jan 202212:15 pmRNSDirector/PDMR Shareholding
20th Jan 202210:30 amRNSDirectorate Change
12th Jan 20222:00 pmRNSCorrection to Director/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.